Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Shares of Edwards Lifesciences Corp. rallied 6.92% to $75.82 Wednesday, on what proved to be an all-around grim trading ...
Edwards Lifesciences price target raised to $71 from $66 at Canaccord
Canaccord raised the firm’s price target on Edwards Lifesciences (EW) to $71 from $66 and keeps a Hold rating on the shares. The firm said they ...
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Edwards Lifesciences (NYSE:EW – Get Free Report) had its price objective upped by Morgan Stanley from $70.00 to $75.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an ...
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...
Edwards Lifesciences price target raised to $90 from $88 at Barclays
Barclays analyst Matt Miksic raised the firm’s price target on Edwards Lifesciences (EW) to $90 from $88 and keeps an Overweight rating on the ...
Medscape1d
Shunt System Still Improving HF Symptoms at 2 Years
A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...
TheBetterIndia1d
Why Women’s Hearts Deserve Better—and How Science Is Finally Catching Up
Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.
Yahoo Finance3d
Edwards Lifesciences Corporation (EW)
Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat. On Tuesday, Edwards Lifesciences (NYSE:EW) reported fourth-quarter sales ...
Investor's Business Daily on MSN2d
Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion
Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.